N1-methyl-2-pyridone-5-carboxamide
2 papers1 finding
- Human trial1
Interventions
1Nicotinamide adenine dinucleotide
upin humans1
1 study
Nicotinamide adenine dinucleotide
upin humans1
Nicotinamide adenine dinucleotide increases N1-methyl-2-pyridone-5-carboxamide in humans (p=2.95e-16).
“N1-methyl-2-pyridone-5-carboxamide, 2PY p=2.95e −16 ), consistent with downstream engagement of NAD metabolic flux.”
Human trialhealthy adultsplasma5 daysn = 50
bioRxiv (Cold Spring Harbor Laboratory)27 Mar 2026Preprint
Latest
2 in 12 monthsbioRxiv
Oral LNAD+ Rapidly Elevates Intracellular NAD and Metabolic Flux Without Elevating Circulating NAD: Evidence from a Randomized Controlled Trial
Preprint: randomised trial in 50 peopleInterventions
Experimental Eye Research
Short-term high-dose nicotinamide treatment across glaucoma subtypes reveals increased mtDNA content and minimal metabolomic change in blood
Trial in peopleInterventions
Journal of Drugs in Dermatology
Exploring the Cardiovascular Impacts of Oral Nicotinamide: A Comprehensive Narrative Review
ReviewCardiovascular disease